PREMCHAND GANDRA,SARAH WORDEN,MURUGESAN RANGASAMY,MEGHAN L. F. FREY,ELANE FISHILEVICH,KENNETH NARVA
申请号：
ARP160101519
公开号：
AR104750A1
申请日:
2016.05.26
申请国别(地区):
AR
年份:
2017
代理人:
摘要：
1. Claim 1: a single nucleic acid, including at least one polynucleotide that is operatively linked to an asexual developer, in which case, the polynucleotide is selected from the following groups: ID No.1； sec supply No.1； sec ID No.1； at least 15 segments of the contiguous nucleic acid； sec ID No.1； Supplement at least 15 Sec1 fragments of continuous nucleic acids； local coding sequence of a blood organism including Sec1； local coding sequence of a blood organism including Sec1； supplement local coding sequence of a blood organism including Sec1；There are at least 15 contiguous nucleotide segments in the local coding sequence of a blood organism, including the segment of SEC No. 1； there are at least 15 contiguous nucleotide segments in the local coding sequence of a blood organism (including the segment of SEC No. 1). Claim 5: a dinucleotide molecule extracted from the polynucleotide of claim 1. Claim 11: according to claim 1, a plant transformation vector containing polynucleotide,There, the hetero developer is a plant cell function. Requirement 12: a cell converted to polynucleotide in requirement 1. Claim 16: one polynucleotide conversion plant in claim 1. Claim 17: seeds of claim 16, including polynucleotide. Claim 25: a method for controlling Haemophilus group, including: providing a modified plant cell in a host plant, including polynucleotide as described in claim 1,In this case, polynucleotide is expressed as the production of a nucleic acid molecule, which is in contact with the blood cell plague in the population to inhibit the expression of objective sequences in the blood cell plague, resulting in the decrease of the growth and / or survival rate of the blood cell plague. In a parasitic plant without polynucleotide, a group of pests related to the same pest.Reivindicación 1: Un ácido nucleico aislado que comprende al menos un polinucleótido operativamente enlazado a un promotor heterólogo, donde el polinucleótido se selecciona del grupo que consiste e
